查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1446409

白蛋白市场：按类型、应用、销售管道分类：2023-2032 年全球机会分析与产业预测

Albumin Market By Type, By Application, By Sales Channel : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 287 Pages | 商品交期: 2-3个工作天内

价格
白蛋白市场-IMG1

此外，白蛋白市场的成长是由主要产业参与者不断实施关键策略（如产品发布、收购和协议）所推动的。

例如，2020年9月，生命科学研究和生物製药行业领先的国际合作伙伴赛多利斯集团宣布收购基于重组白蛋白的解决方案领域的领导者Albumedix Ltd。此外，全球大型公司的血浆源药物製造商 Grifols 宣布推出其白蛋白产品组合的最新创新产品 ALBUTEIN FlexBag，浓度为 5% 和 25%。此类策略措施不仅推动创新，还透过满足医疗保健和生物製药行业不断变化的需求来加速市场成长。

此外，技术进步也是白蛋白市场成长的主要驱动因素。在製药和生物技术领域，生产製程和精製技术的不断创新正在提高白蛋白产品的效率和品质。先进技术也有助于开发新型白蛋白製剂，扩大其在药物传递系统和诊断的应用。製造、精製和分析的高精度确保了杂质最少的高品质白蛋白，并满足严格的监管标准。此外，技术进步将有助于探索白蛋白生产的替代来源并解决供应链挑战。技术与白蛋白生产之间的协同效应不仅改进了现有产品，而且促进了尖端解决方案的创建，并推动了白蛋白市场的整体扩张。

白蛋白市场按类型、应用、销售管道和地区细分。依类型分为人类血清白蛋白、牛血清白蛋白、重组白蛋白。依用途分为治疗药物、製剂/疫苗、培养基成分等。依销售管道划分，销售分为企业对企业（B2B）及消费者对消费者（B2C）。按地区划分，我们有北美（美国、加拿大、墨西哥）、欧洲（德国、英国、英国、义大利、西班牙其他欧洲国家地区）、亚太地区（日本、中国、印度、澳洲、韩国、其他亚太地区），在亚太地区（巴西、中国、阿拉伯、亚太其他地区）进行分析。

相关人员的主要利益

  • 本报告对 2022 年至 2032 年白蛋白市场分析的细分市场、当前趋势、估计/趋势分析和动态进行了定量分析，以确定白蛋白市场的有前景的机会。
  • 我们提供市场研究以及与市场驱动因素、市场限制和市场机会相关的资讯。
  • 波特的五力分析强调买家和供应商帮助相关人员做出利润驱动的商业决策并加强供应商-买家网路的潜力。
  • 对白蛋白市场细分的详细分析将有助于确定市场机会。
  • 每个地区的主要国家都根据其对全球市场的收益贡献绘製了地图。
  • 市场公司定位有助于基准化分析并提供对市场公司当前地位的清晰了解。
  • 该报告包括对区域和全球白蛋白市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

可以使用此报告进行报告客製化（可能需要额外费用和时间表）

  • 国家、区域和全球各级的患者/流行病学资料
  • 监管指引
  • 针对客户兴趣的其他公司简介
  • 公司简介的扩充列表
  • 历史市场资料
  • 赎回场景
  • SWOT分析

目录

第一章简介

第 2 章执行摘要

第三章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
      • 手术数量增加
      • 提高捐血意识
      • 在药物开发中增加血浆来源白蛋白的使用
    • 抑制因素
      • 严格的政府法规
    • 机会
      • 新兴市场的成长机会

第四章白蛋白市场：依类型

  • 概述
  • 人血清白蛋白
  • 牛血清白蛋白
  • 基因改造白蛋白

第五章白蛋白市场：依应用分类

  • 概述
  • 治疗药物
  • 药物製剂和疫苗
  • 中等成分
  • 其他的

第六章白蛋白市场：依销售管道分类

  • 概述
  • B2C
  • B2B
    • B2B 白蛋白市场：依类型
      • 药用白蛋白市场：依类型
      • 非医用白蛋白市场：依类型

第七章按地区分類的白蛋白市场

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲/中东/非洲
    • 巴西
    • 沙乌地阿拉伯
    • 南非
    • 其他的

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 2022年主要企业定位

第九章 公司简介

  • Merck KGaA
  • Sartorius AG
  • Octapharma AG
  • Thermo Fisher Scientific Inc.
  • Ventria Bioscience Inc.
  • Grifols, SA
  • CSL
  • China Biologic Products Holdings, Inc
  • Lazuline Bio
  • Takeda Pharmaceutical Company Limited
Product Code: A02251
Albumin Market - IMG1

Furthermore, the growth of the albumin market is propelled by the increasing implementation of key strategies among major industry players, including product launches, acquisitions, and agreements. For instance, in September 2020, Sartorius Group, a leading international partner of life science research and the biopharmaceutical industry, announced acquisition of Albumedix Ltd, a leader in the field of recombinant albumin-based solutions. In addition, Grifols, a leading global producer of plasma-derived medicines, announced the launch of its latest albumin portfolio innovation, ALBUTEIN FlexBag (Albumin [Human] U.S.P.) in 5% and 25% concentrations. These strategic moves not only drive innovation but also foster market growth by catering to the evolving needs of the healthcare and biopharmaceutical industries.

In addition, technological advancements are key drivers of the growing albumin market. In the pharmaceutical and biotechnology sectors, continuous innovations in production processes and purification techniques enhance the efficiency and quality of albumin products. Advanced technologies also contribute to the development of novel albumin-based formulations, expanding their applications in drug delivery systems and diagnostics. Precision in manufacturing, purification, and analysis ensures high-quality albumin with minimal impurities, meeting stringent regulatory standards. In addition, technological progress facilitates the exploration of alternative sources for albumin production, addressing supply chain challenges. The synergy between technology and albumin production not only improves existing products but also fosters the creation of cutting-edge solutions, fueling the overall expansion of the albumin market.

The albumin market is segmented on the basis of type, application, sales channel, and region. On the basis of type, the market is categorized into human serum albumin, bovine serum albumin, and recombinant albumin. On the basis of application, it is classified into therapeutics, drug formulation & vaccines, component of media, and others. On the basis of sales channel, it is classified into business to business (B2B) and business to consumer (B2C). On the basis of region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major key players that operate in the global albumin market are Takeda Pharmaceutical Company Limited, Merck KGaA, Sartorius AG, Octapharma AG, Thermo Fisher Scientific Inc., Ventria Bioscience Inc, Grifols, S.A., CSL, China Biologic Products Holdings, Inc, and Lazuline Bio. The players have adopted investment, strategic alliance, product approval, clinical trials, expansion, agreement, and acquisition as the key strategies to expand their product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the albumin market analysis from 2022 to 2032 to identify the prevailing albumin market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the albumin market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global albumin market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • Reimbursement Scenario
  • SWOT Analysis

Key Market Segments

By Type

  • Human Serum Albumin
  • Bovine Serum Albumin
  • Recombinant Albumin

By Application

  • Therapeutics
  • Drug Formulation and Vaccines
  • Component of Media
  • Other

By Sales Channel

  • B2C
  • B2B
    • Type
    • Pharmaceutical Applications

Type

    • Non Pharmaceutical Applications

Type

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Octapharma AG
    • Grifols, S.A.
    • CSL
    • Ventria Bioscience Inc.
    • Lazuline Bio
    • Takeda Pharmaceutical Company Limited
    • Sartorius AG
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • China Biologic Products Holdings, Inc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in number of surgical procedures
      • 3.4.1.2. Growing awareness regarding blood donations.
      • 3.4.1.3. Rise in use of plasma derived albumin in drug development
    • 3.4.2. Restraints
      • 3.4.2.1. Stringent government regulations
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth opportunities in emerging markets

CHAPTER 4: ALBUMIN MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Human Serum Albumin
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Bovine Serum Albumin
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Recombinant Albumin
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: ALBUMIN MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Therapeutics
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Drug Formulation and Vaccines
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Component of Media
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Other
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: ALBUMIN MARKET, BY SALES CHANNEL

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. B2C
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. B2B
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
    • 6.3.4. B2B Albumin Market by Type
      • 6.3.4.1. Pharmaceutical Applications Albumin Market by Type
      • 6.3.4.2. Non Pharmaceutical Applications Albumin Market by Type

CHAPTER 7: ALBUMIN MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by Sales Channel
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Type
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.3. Market size and forecast, by Sales Channel
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Type
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.3. Market size and forecast, by Sales Channel
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Type
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.3. Market size and forecast, by Sales Channel
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by Sales Channel
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Type
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.3. Market size and forecast, by Sales Channel
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Type
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.3. Market size and forecast, by Sales Channel
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Type
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.3. Market size and forecast, by Sales Channel
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Type
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.3. Market size and forecast, by Sales Channel
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Type
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.3. Market size and forecast, by Sales Channel
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Type
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.3. Market size and forecast, by Sales Channel
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by Sales Channel
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Type
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.3. Market size and forecast, by Sales Channel
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Type
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.3. Market size and forecast, by Sales Channel
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Type
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.3. Market size and forecast, by Sales Channel
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Type
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.3. Market size and forecast, by Sales Channel
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Type
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.3. Market size and forecast, by Sales Channel
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Type
      • 7.4.5.6.2. Market size and forecast, by Application
      • 7.4.5.6.3. Market size and forecast, by Sales Channel
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by Sales Channel
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Type
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.3. Market size and forecast, by Sales Channel
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Type
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.3. Market size and forecast, by Sales Channel
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Type
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.3. Market size and forecast, by Sales Channel
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Type
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.3. Market size and forecast, by Sales Channel

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Merck KGaA
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Sartorius AG
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Octapharma AG
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.7. Key strategic moves and developments
  • 9.4. Thermo Fisher Scientific Inc.
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Ventria Bioscience Inc.
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
  • 9.6. Grifols, S.A.
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. CSL
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. China Biologic Products Holdings, Inc
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. Lazuline Bio
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. Takeda Pharmaceutical Company Limited
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance
    • 9.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. ALBUMIN MARKET FOR HUMAN SERUM ALBUMIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. ALBUMIN MARKET FOR BOVINE SERUM ALBUMIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. ALBUMIN MARKET FOR RECOMBINANT ALBUMIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 06. ALBUMIN MARKET FOR THERAPEUTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. ALBUMIN MARKET FOR DRUG FORMULATION AND VACCINES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. ALBUMIN MARKET FOR COMPONENT OF MEDIA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. ALBUMIN MARKET FOR OTHER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 11. ALBUMIN MARKET FOR B2C, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. ALBUMIN MARKET FOR B2B, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL B2B ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL APPLICATIONS ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL NON PHARMACEUTICAL APPLICATIONS ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 16. ALBUMIN MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA ALBUMIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 21. U.S. ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 22. U.S. ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. U.S. ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 24. CANADA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 25. CANADA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. CANADA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE ALBUMIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 34. GERMANY ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 35. GERMANY ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. GERMANY ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 38. FRANCE ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. FRANCE ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 40. UK ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 41. UK ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. UK ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 43. ITALY ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 44. ITALY ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. ITALY ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 46. SPAIN ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 47. SPAIN ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. SPAIN ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 49. REST OF EUROPE ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 50. REST OF EUROPE ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. REST OF EUROPE ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC ALBUMIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 56. JAPAN ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. JAPAN ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 59. CHINA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. CHINA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. CHINA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 62. INDIA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 63. INDIA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. INDIA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 65. AUSTRALIA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. AUSTRALIA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. AUSTRALIA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. SOUTH KOREA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 71. REST OF ASIA-PACIFIC ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 72. REST OF ASIA-PACIFIC ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. REST OF ASIA-PACIFIC ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 74. LAMEA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 75. LAMEA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. LAMEA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 77. LAMEA ALBUMIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 78. BRAZIL ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 79. BRAZIL ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 80. BRAZIL ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 81. SAUDI ARABIA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 82. SAUDI ARABIA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. SAUDI ARABIA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 84. SOUTH AFRICA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH AFRICA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH AFRICA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 87. REST OF LAMEA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 88. REST OF LAMEA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 89. REST OF LAMEA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 90. MERCK KGAA: KEY EXECUTIVES
  • TABLE 91. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 92. MERCK KGAA: PRODUCT SEGMENTS
  • TABLE 93. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 94. SARTORIUS AG: KEY EXECUTIVES
  • TABLE 95. SARTORIUS AG: COMPANY SNAPSHOT
  • TABLE 96. SARTORIUS AG: PRODUCT SEGMENTS
  • TABLE 97. SARTORIUS AG: PRODUCT PORTFOLIO
  • TABLE 98. SARTORIUS AG: KEY STRATERGIES
  • TABLE 99. OCTAPHARMA AG: KEY EXECUTIVES
  • TABLE 100. OCTAPHARMA AG: COMPANY SNAPSHOT
  • TABLE 101. OCTAPHARMA AG: PRODUCT SEGMENTS
  • TABLE 102. OCTAPHARMA AG: PRODUCT PORTFOLIO
  • TABLE 103. OCTAPHARMA AG: KEY STRATERGIES
  • TABLE 104. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
  • TABLE 105. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
  • TABLE 106. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
  • TABLE 107. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
  • TABLE 108. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
  • TABLE 109. VENTRIA BIOSCIENCE INC.: KEY EXECUTIVES
  • TABLE 110. VENTRIA BIOSCIENCE INC.: COMPANY SNAPSHOT
  • TABLE 111. VENTRIA BIOSCIENCE INC.: PRODUCT SEGMENTS
  • TABLE 112. VENTRIA BIOSCIENCE INC.: PRODUCT PORTFOLIO
  • TABLE 113. GRIFOLS, S.A.: KEY EXECUTIVES
  • TABLE 114. GRIFOLS, S.A.: COMPANY SNAPSHOT
  • TABLE 115. GRIFOLS, S.A.: PRODUCT SEGMENTS
  • TABLE 116. GRIFOLS, S.A.: PRODUCT PORTFOLIO
  • TABLE 117. GRIFOLS, S.A.: KEY STRATERGIES
  • TABLE 118. CSL: KEY EXECUTIVES
  • TABLE 119. CSL: COMPANY SNAPSHOT
  • TABLE 120. CSL: PRODUCT SEGMENTS
  • TABLE 121. CSL: PRODUCT PORTFOLIO
  • TABLE 122. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC: KEY EXECUTIVES
  • TABLE 123. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC: COMPANY SNAPSHOT
  • TABLE 124. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC: PRODUCT SEGMENTS
  • TABLE 125. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC: PRODUCT PORTFOLIO
  • TABLE 126. LAZULINE BIO: KEY EXECUTIVES
  • TABLE 127. LAZULINE BIO: COMPANY SNAPSHOT
  • TABLE 128. LAZULINE BIO: PRODUCT SEGMENTS
  • TABLE 129. LAZULINE BIO: PRODUCT PORTFOLIO
  • TABLE 130. TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY EXECUTIVES
  • TABLE 131. TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY SNAPSHOT
  • TABLE 132. TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCT SEGMENTS
  • TABLE 133. TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCT PORTFOLIO
  • TABLE 134. TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. ALBUMIN MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF ALBUMIN MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN ALBUMIN MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN ALBUMIN MARKET (2023-2032)
  • FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 07. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL ALBUMIN MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. ALBUMIN MARKET, BY TYPE, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR HUMAN SERUM ALBUMIN, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR BOVINE SERUM ALBUMIN, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR RECOMBINANT ALBUMIN, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. ALBUMIN MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR THERAPEUTICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR DRUG FORMULATION AND VACCINES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR COMPONENT OF MEDIA, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR OTHER, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. ALBUMIN MARKET, BY SALES CHANNEL, 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR B2C, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR B2B, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. ALBUMIN MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 24. U.S. ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. CANADA ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. MEXICO ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. GERMANY ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. FRANCE ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. UK ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. ITALY ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. SPAIN ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. REST OF EUROPE ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. JAPAN ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. CHINA ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. INDIA ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. AUSTRALIA ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. SOUTH KOREA ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. REST OF ASIA-PACIFIC ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. BRAZIL ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. SAUDI ARABIA ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. SOUTH AFRICA ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. REST OF LAMEA ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
  • FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
  • FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
  • FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47. COMPETITIVE DASHBOARD
  • FIGURE 48. COMPETITIVE HEATMAP: ALBUMIN MARKET
  • FIGURE 49. TOP PLAYER POSITIONING, 2022
  • FIGURE 50. MERCK KGAA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. MERCK KGAA: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 52. MERCK KGAA: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 53. SARTORIUS AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. SARTORIUS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 55. SARTORIUS AG: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 56. OCTAPHARMA AG: SALES REVENUE, 2020-2022 ($MILLION)
  • FIGURE 57. THERMO FISHER SCIENTIFIC INC. : NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 58. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 59. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 60. GRIFOLS, S.A.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. GRIFOLS, S.A.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 62. GRIFOLS, S.A.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 63. CSL: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 64. CSL: REVENUE SHARE BY SEGMENT, 2023 (%)
  • FIGURE 65. CSL: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 66. TAKEDA PHARMACEUTICAL COMPANY LIMITED: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 67. TAKEDA PHARMACEUTICAL COMPANY LIMITED: REVENUE SHARE BY REGION, 2023 (%)